nodes	percent_of_prediction	percent_of_DWPC	metapath
Theobromine—ADORA2A—Parkinson's disease	0.674	0.766	CbGaD
Theobromine—CYP2E1—Parkinson's disease	0.206	0.234	CbGaD
Theobromine—ADORA1—nerve—Parkinson's disease	0.00338	0.116	CbGeAlD
Theobromine—Enprofylline—ADORA2A—Parkinson's disease	0.00247	0.303	CrCbGaD
Theobromine—ADORA2A—forebrain—Parkinson's disease	0.00162	0.0557	CbGeAlD
Theobromine—Pentoxifylline—ADORA2A—Parkinson's disease	0.00155	0.191	CrCbGaD
Theobromine—ADORA1—forebrain—Parkinson's disease	0.0014	0.0481	CbGeAlD
Theobromine—ADORA2A—cardiovascular system—Parkinson's disease	0.00137	0.0471	CbGeAlD
Theobromine—Dyphylline—ADORA2A—Parkinson's disease	0.00126	0.155	CrCbGaD
Theobromine—ADORA1—cardiovascular system—Parkinson's disease	0.00118	0.0407	CbGeAlD
Theobromine—ADORA2A—spinal cord—Parkinson's disease	0.00104	0.0359	CbGeAlD
Theobromine—PDE4B—forebrain—Parkinson's disease	0.00104	0.0356	CbGeAlD
Theobromine—ADORA1—medulla oblongata—Parkinson's disease	0.00101	0.0347	CbGeAlD
Theobromine—ADORA2A—head—Parkinson's disease	0.000928	0.0319	CbGeAlD
Theobromine—ADORA1—midbrain—Parkinson's disease	0.000925	0.0318	CbGeAlD
Theobromine—ADORA1—spinal cord—Parkinson's disease	0.000902	0.031	CbGeAlD
Theobromine—Theophylline—ADORA2A—Parkinson's disease	0.000896	0.11	CrCbGaD
Theobromine—ADORA2A—nervous system—Parkinson's disease	0.00088	0.0302	CbGeAlD
Theobromine—Caffeine—ADORA2A—Parkinson's disease	0.00088	0.108	CrCbGaD
Theobromine—ADORA2A—central nervous system—Parkinson's disease	0.000848	0.0291	CbGeAlD
Theobromine—ADORA2A—cerebellum—Parkinson's disease	0.000828	0.0285	CbGeAlD
Theobromine—ADORA1—head—Parkinson's disease	0.000802	0.0275	CbGeAlD
Theobromine—ADORA1—nervous system—Parkinson's disease	0.00076	0.0261	CbGeAlD
Theobromine—PDE4B—medulla oblongata—Parkinson's disease	0.000748	0.0257	CbGeAlD
Theobromine—ADORA1—central nervous system—Parkinson's disease	0.000732	0.0251	CbGeAlD
Theobromine—ADORA1—cerebellum—Parkinson's disease	0.000715	0.0246	CbGeAlD
Theobromine—PDE4B—midbrain—Parkinson's disease	0.000684	0.0235	CbGeAlD
Theobromine—ADORA2A—brain—Parkinson's disease	0.000673	0.0231	CbGeAlD
Theobromine—PDE4B—spinal cord—Parkinson's disease	0.000667	0.0229	CbGeAlD
Theobromine—PDE4B—head—Parkinson's disease	0.000593	0.0204	CbGeAlD
Theobromine—ADORA1—brain—Parkinson's disease	0.000581	0.02	CbGeAlD
Theobromine—PDE4B—nervous system—Parkinson's disease	0.000562	0.0193	CbGeAlD
Theobromine—PDE4B—central nervous system—Parkinson's disease	0.000541	0.0186	CbGeAlD
Theobromine—PDE4B—cerebellum—Parkinson's disease	0.000529	0.0182	CbGeAlD
Theobromine—CYP2E1—cardiovascular system—Parkinson's disease	0.000484	0.0166	CbGeAlD
Theobromine—PDE4B—brain—Parkinson's disease	0.00043	0.0148	CbGeAlD
Theobromine—CYP2E1—medulla oblongata—Parkinson's disease	0.000413	0.0142	CbGeAlD
Theobromine—CYP2E1—spinal cord—Parkinson's disease	0.000369	0.0127	CbGeAlD
Theobromine—CYP2E1—head—Parkinson's disease	0.000328	0.0113	CbGeAlD
Theobromine—CYP2E1—nervous system—Parkinson's disease	0.000311	0.0107	CbGeAlD
Theobromine—CYP2E1—central nervous system—Parkinson's disease	0.000299	0.0103	CbGeAlD
Theobromine—CYP2E1—cerebellum—Parkinson's disease	0.000292	0.01	CbGeAlD
Theobromine—Theophylline—CYP2E1—Parkinson's disease	0.000274	0.0337	CrCbGaD
Theobromine—Caffeine—CYP2E1—Parkinson's disease	0.000269	0.0331	CrCbGaD
Theobromine—CYP2E1—brain—Parkinson's disease	0.000237	0.00816	CbGeAlD
Theobromine—Theophylline—CYP2D6—Parkinson's disease	0.000201	0.0247	CrCbGaD
Theobromine—Caffeine—CYP2D6—Parkinson's disease	0.000198	0.0243	CrCbGaD
Theobromine—Caffeine—ABCB1—Parkinson's disease	0.000141	0.0173	CrCbGaD
Theobromine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	9.14e-05	0.0011	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—RIT2—Parkinson's disease	9.12e-05	0.0011	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—HTR2A—Parkinson's disease	9.02e-05	0.00109	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—RIT2—Parkinson's disease	9.01e-05	0.00109	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—ADORA2A—Parkinson's disease	9e-05	0.00108	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—GRM5—Parkinson's disease	9e-05	0.00108	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	8.98e-05	0.00108	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—ADORA2A—Parkinson's disease	8.89e-05	0.00107	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DGKQ—Parkinson's disease	8.81e-05	0.00106	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—GPR37—Parkinson's disease	8.81e-05	0.00106	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—PDYN—Parkinson's disease	8.79e-05	0.00106	CbGpPWpGaD
Theobromine—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	8.65e-05	0.00104	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—GRK5—Parkinson's disease	8.65e-05	0.00104	CbGpPWpGaD
Theobromine—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	8.61e-05	0.00104	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—HTR1A—Parkinson's disease	8.6e-05	0.00104	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—GRK5—Parkinson's disease	8.55e-05	0.00103	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—HTR1A—Parkinson's disease	8.5e-05	0.00102	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—TAC1—Parkinson's disease	8.47e-05	0.00102	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—COMT—Parkinson's disease	8.42e-05	0.00101	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	8.38e-05	0.00101	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—TAC1—Parkinson's disease	8.37e-05	0.00101	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	8.36e-05	0.00101	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD1—Parkinson's disease	8.3e-05	0.001	CbGpPWpGaD
Theobromine—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	8.3e-05	0.001	CbGpPWpGaD
Theobromine—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	8.26e-05	0.000995	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD1—Parkinson's disease	8.21e-05	0.000989	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—GRM5—Parkinson's disease	8.17e-05	0.000984	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PPP1R1B—Parkinson's disease	8.06e-05	0.000971	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD3—Parkinson's disease	8.04e-05	0.000969	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—EDN1—Parkinson's disease	7.96e-05	0.000958	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD3—Parkinson's disease	7.95e-05	0.000957	CbGpPWpGaD
Theobromine—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	7.91e-05	0.000953	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HTR1A—Parkinson's disease	7.81e-05	0.000941	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—GRM4—Parkinson's disease	7.76e-05	0.000934	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HTR1A—Parkinson's disease	7.72e-05	0.000929	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	7.7e-05	0.000927	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—TAC1—Parkinson's disease	7.69e-05	0.000926	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—GRM4—Parkinson's disease	7.66e-05	0.000923	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—TAC1—Parkinson's disease	7.6e-05	0.000915	CbGpPWpGaD
Theobromine—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	7.59e-05	0.000915	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD1—Parkinson's disease	7.54e-05	0.000908	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.51e-05	0.000905	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD1—Parkinson's disease	7.45e-05	0.000898	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.42e-05	0.000894	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PENK—Parkinson's disease	7.35e-05	0.000886	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MAG—Parkinson's disease	7.35e-05	0.000886	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD3—Parkinson's disease	7.3e-05	0.00088	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—DRD2—Parkinson's disease	7.27e-05	0.000876	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—HTR7—Parkinson's disease	7.27e-05	0.000876	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MAG—Parkinson's disease	7.27e-05	0.000875	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PENK—Parkinson's disease	7.27e-05	0.000875	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD3—Parkinson's disease	7.22e-05	0.000869	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—HTR7—Parkinson's disease	7.19e-05	0.000866	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—DRD2—Parkinson's disease	7.19e-05	0.000866	CbGpPWpGaD
Theobromine—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—Parkinson's disease	7.12e-05	0.000858	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—MAPK8—Parkinson's disease	7.08e-05	0.000853	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—RIT2—Parkinson's disease	7.04e-05	0.000848	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	6.97e-05	0.00084	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—HTR2A—Parkinson's disease	6.96e-05	0.000838	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—ADRBK1—Parkinson's disease	6.82e-05	0.000822	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—ADRBK1—Parkinson's disease	6.74e-05	0.000812	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PDYN—Parkinson's disease	6.73e-05	0.00081	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—GRK5—Parkinson's disease	6.68e-05	0.000804	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	6.68e-05	0.000804	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PDYN—Parkinson's disease	6.65e-05	0.000801	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—HTR1A—Parkinson's disease	6.64e-05	0.0008	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HTR7—Parkinson's disease	6.61e-05	0.000796	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—DRD2—Parkinson's disease	6.61e-05	0.000796	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.58e-05	0.000793	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—TAC1—Parkinson's disease	6.54e-05	0.000788	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HTR7—Parkinson's disease	6.53e-05	0.000786	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—DRD2—Parkinson's disease	6.53e-05	0.000786	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD1—Parkinson's disease	6.41e-05	0.000772	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—GFAP—Parkinson's disease	6.32e-05	0.000762	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—GRM5—Parkinson's disease	6.25e-05	0.000753	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—GFAP—Parkinson's disease	6.25e-05	0.000753	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD3—Parkinson's disease	6.21e-05	0.000748	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—GRM5—Parkinson's disease	6.18e-05	0.000744	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	6.11e-05	0.000736	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HTR1A—Parkinson's disease	6.03e-05	0.000726	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.02e-05	0.000725	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—GRM4—Parkinson's disease	5.99e-05	0.000721	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—TAC1—Parkinson's disease	5.94e-05	0.000715	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—IL6—Parkinson's disease	5.86e-05	0.000705	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—EDN1—Parkinson's disease	5.82e-05	0.000702	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD1—Parkinson's disease	5.82e-05	0.000701	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—CASP3—Parkinson's disease	5.81e-05	0.0007	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.8e-05	0.000699	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—EDN1—Parkinson's disease	5.75e-05	0.000693	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PENK—Parkinson's disease	5.68e-05	0.000684	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MAG—Parkinson's disease	5.68e-05	0.000684	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD3—Parkinson's disease	5.64e-05	0.000679	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—DRD2—Parkinson's disease	5.62e-05	0.000677	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—HTR7—Parkinson's disease	5.62e-05	0.000677	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	5.58e-05	0.000673	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—FGF20—Parkinson's disease	5.48e-05	0.00066	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ND3—Parkinson's disease	5.46e-05	0.000657	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—MCCC1—Parkinson's disease	5.46e-05	0.000657	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—FGF20—Parkinson's disease	5.42e-05	0.000653	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—MAPK8—Parkinson's disease	5.34e-05	0.000643	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ADORA2A—Parkinson's disease	5.32e-05	0.00064	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—EDN1—Parkinson's disease	5.29e-05	0.000637	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—ADRBK1—Parkinson's disease	5.27e-05	0.000634	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ADORA2A—Parkinson's disease	5.25e-05	0.000633	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—EDN1—Parkinson's disease	5.23e-05	0.000629	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PDYN—Parkinson's disease	5.19e-05	0.000626	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—TALDO1—Parkinson's disease	5.13e-05	0.000618	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—OMD—Parkinson's disease	5.13e-05	0.000618	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HTR7—Parkinson's disease	5.1e-05	0.000614	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—DRD2—Parkinson's disease	5.1e-05	0.000614	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.09e-05	0.000614	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—COMT—Parkinson's disease	5.06e-05	0.000609	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	5.06e-05	0.000609	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	5.06e-05	0.000609	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	5.04e-05	0.000607	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—HTR2A—Parkinson's disease	5.03e-05	0.000606	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	5.02e-05	0.000605	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	4.99e-05	0.000601	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	4.97e-05	0.000598	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—INSR—Parkinson's disease	4.91e-05	0.000591	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—GFAP—Parkinson's disease	4.88e-05	0.000588	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	4.86e-05	0.000586	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—INSR—Parkinson's disease	4.85e-05	0.000584	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—GRM5—Parkinson's disease	4.83e-05	0.000582	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GCH1—Parkinson's disease	4.64e-05	0.000559	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—FGB—Parkinson's disease	4.64e-05	0.000559	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	4.63e-05	0.000557	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HTR2A—Parkinson's disease	4.63e-05	0.000557	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HTR1A—Parkinson's disease	4.61e-05	0.000556	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—FGB—Parkinson's disease	4.58e-05	0.000552	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HTR2A—Parkinson's disease	4.57e-05	0.000551	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	4.56e-05	0.00055	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HTR1A—Parkinson's disease	4.56e-05	0.000549	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TAC1—Parkinson's disease	4.54e-05	0.000547	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—IL6—Parkinson's disease	4.52e-05	0.000545	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—EDN1—Parkinson's disease	4.5e-05	0.000542	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TAC1—Parkinson's disease	4.49e-05	0.000541	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD1—Parkinson's disease	4.46e-05	0.000537	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	4.43e-05	0.000534	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD1—Parkinson's disease	4.4e-05	0.00053	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD3—Parkinson's disease	4.31e-05	0.00052	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD3—Parkinson's disease	4.26e-05	0.000514	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—FGF20—Parkinson's disease	4.23e-05	0.00051	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GBA—Parkinson's disease	4.14e-05	0.000498	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—FBP1—Parkinson's disease	4.14e-05	0.000498	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—DBH—Parkinson's disease	4.14e-05	0.000498	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—EDN1—Parkinson's disease	4.08e-05	0.000492	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ADRBK1—Parkinson's disease	4.03e-05	0.000485	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ADRBK1—Parkinson's disease	3.98e-05	0.00048	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	3.93e-05	0.000474	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—DRD2—Parkinson's disease	3.9e-05	0.00047	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HTR7—Parkinson's disease	3.9e-05	0.00047	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—DRD2—Parkinson's disease	3.86e-05	0.000464	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HTR7—Parkinson's disease	3.86e-05	0.000464	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—INSR—Parkinson's disease	3.79e-05	0.000456	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—FGB—Parkinson's disease	3.58e-05	0.000431	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HTR2A—Parkinson's disease	3.57e-05	0.00043	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HTR1A—Parkinson's disease	3.56e-05	0.000429	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TAC1—Parkinson's disease	3.51e-05	0.000423	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.48e-05	0.00042	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD1—Parkinson's disease	3.44e-05	0.000414	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—IL6—Parkinson's disease	3.41e-05	0.000411	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD3—Parkinson's disease	3.33e-05	0.000401	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MCCC1—Parkinson's disease	3.28e-05	0.000395	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ND3—Parkinson's disease	3.28e-05	0.000395	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IGF2—Parkinson's disease	3.27e-05	0.000394	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IGF2—Parkinson's disease	3.23e-05	0.000389	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IGF1R—Parkinson's disease	3.16e-05	0.000381	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—EDN1—Parkinson's disease	3.12e-05	0.000376	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IGF1R—Parkinson's disease	3.12e-05	0.000376	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ADRBK1—Parkinson's disease	3.11e-05	0.000375	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—EDN1—Parkinson's disease	3.09e-05	0.000372	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	3.08e-05	0.000372	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—OMD—Parkinson's disease	3.08e-05	0.000372	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—DDC—Parkinson's disease	3.04e-05	0.000366	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HTR7—Parkinson's disease	3.01e-05	0.000363	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—DRD2—Parkinson's disease	3.01e-05	0.000363	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	2.92e-05	0.000352	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—NGF—Parkinson's disease	2.87e-05	0.000346	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTA4—Parkinson's disease	2.87e-05	0.000345	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—NGF—Parkinson's disease	2.84e-05	0.000342	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GCH1—Parkinson's disease	2.79e-05	0.000336	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HTR2A—Parkinson's disease	2.73e-05	0.000329	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HTR2A—Parkinson's disease	2.7e-05	0.000325	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	2.58e-05	0.000311	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—MAOB—Parkinson's disease	2.56e-05	0.000308	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—APOE—Parkinson's disease	2.54e-05	0.000306	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IGF2—Parkinson's disease	2.52e-05	0.000304	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.52e-05	0.000303	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—APOE—Parkinson's disease	2.51e-05	0.000302	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GBA—Parkinson's disease	2.49e-05	0.0003	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—DBH—Parkinson's disease	2.49e-05	0.0003	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—FBP1—Parkinson's disease	2.49e-05	0.0003	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IGF1R—Parkinson's disease	2.44e-05	0.000294	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—EDN1—Parkinson's disease	2.41e-05	0.000291	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—NGF—Parkinson's disease	2.22e-05	0.000267	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—INS—Parkinson's disease	2.17e-05	0.000261	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—INS—Parkinson's disease	2.14e-05	0.000258	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HTR2A—Parkinson's disease	2.11e-05	0.000254	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—APOE—Parkinson's disease	1.96e-05	0.000236	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.9e-05	0.000229	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.86e-05	0.000225	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—DDC—Parkinson's disease	1.83e-05	0.00022	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.72e-05	0.000208	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.72e-05	0.000207	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.7e-05	0.000205	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—TH—Parkinson's disease	1.69e-05	0.000204	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—INS—Parkinson's disease	1.68e-05	0.000202	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.63e-05	0.000196	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CASP3—Parkinson's disease	1.62e-05	0.000195	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—IL6—Parkinson's disease	1.61e-05	0.000193	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CASP3—Parkinson's disease	1.6e-05	0.000192	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—IL6—Parkinson's disease	1.59e-05	0.000191	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.55e-05	0.000187	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.54e-05	0.000185	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MAPK8—Parkinson's disease	1.49e-05	0.000179	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MAPK8—Parkinson's disease	1.47e-05	0.000177	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.46e-05	0.000176	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—COMT—Parkinson's disease	1.44e-05	0.000173	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.43e-05	0.000173	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.43e-05	0.000172	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.41e-05	0.00017	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.36e-05	0.000163	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.32e-05	0.000159	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GPX1—Parkinson's disease	1.26e-05	0.000152	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CASP3—Parkinson's disease	1.25e-05	0.00015	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL6—Parkinson's disease	1.24e-05	0.000149	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.16e-05	0.00014	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.15e-05	0.000138	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.14e-05	0.000138	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.12e-05	0.000135	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—APOE—Parkinson's disease	1.08e-05	0.00013	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.04e-05	0.000126	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.03e-05	0.000124	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—TH—Parkinson's disease	1.02e-05	0.000123	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYCS—Parkinson's disease	9.77e-06	0.000118	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL6—Parkinson's disease	9.48e-06	0.000114	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL6—Parkinson's disease	9.37e-06	0.000113	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—INS—Parkinson's disease	9.25e-06	0.000111	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—COMT—Parkinson's disease	8.65e-06	0.000104	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	8.61e-06	0.000104	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MAOA—Parkinson's disease	8.59e-06	0.000103	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	8.49e-06	0.000102	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	8.15e-06	9.82e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	7.91e-06	9.53e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GPX1—Parkinson's disease	7.58e-06	9.13e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL6—Parkinson's disease	7.32e-06	8.82e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	6.99e-06	8.42e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—APOE—Parkinson's disease	6.51e-06	7.84e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—INS—Parkinson's disease	5.56e-06	6.7e-05	CbGpPWpGaD
